Aflibercept biosimilar (GlycoNex)

阿柏西普生物类似药 (台湾糖联生技医药股份有限公司)

Report date: 2024/06/05 11:59:43

Base Information

Drug NameAflibercept biosimilar (GlycoNex)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar

Mechanisms of ActionPlacental Growth Factor inhibitorsVascular endothelial growth factor A inhibitors

TargetsVascular endothelial growth factor APlacental Growth Factor

Therapy Area/IndicationsMacular DegenerationColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGlyconex Inc

China Registration ClassN/A

Active CompaniesGlyconex Inc

Inactive CompaniesN/A

Active IndicationsMacular DegenerationColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A